Opexa Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, ACER, Opexa Therapeutics Inc, priceseries

Opexa Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
2.53
Close
2.46
High
2.53
Low
2.38
Previous Close
2.49
Daily Price Gain
-0.03
YTD High
2.76
YTD High Date
Feb 22, 2022
YTD Low
1.84
YTD Low Date
Jan 24, 2022
YTD Price Change
0.11
YTD Gain
4.68%
52 Week High
5.39
52 Week High Date
Mar 15, 2021
52 Week Low
1.68
52 Week Low Date
Dec 6, 2021
52 Week Price Change
-0.37
52 Week Gain
-13.07%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 12. 2017
11.91
Jan 13. 2017
13.05
1 Trading Days
9.57%
Link
LONG
Feb 14. 2017
11.49
Feb 15. 2017
12.27
1 Trading Days
6.76%
Link
LONG
Jul 3. 2017
12.12
Jul 5. 2017
13.57
1 Trading Days
11.97%
Link
LONG
Sep 6. 2017
9.22
Sep 20. 2017
9.97
10 Trading Days
8.16%
Link
LONG
Sep 25. 2017
11.00
Oct 18. 2017
17.19
17 Trading Days
56.29%
Link
LONG
Dec 29. 2017
13.85
Feb 2. 2018
18.72
23 Trading Days
35.14%
Link
LONG
Aug 3. 2018
21.10
Aug 16. 2018
26.27
9 Trading Days
24.52%
Link
LONG
Aug 17. 2018
28.94
Sep 6. 2018
31.32
13 Trading Days
8.24%
Link
LONG
Dec 31. 2018
20.12
Jan 24. 2019
24.12
16 Trading Days
19.89%
Link
LONG
Sep 4. 2019
2.60
Sep 24. 2019
3.34
14 Trading Days
28.63%
Link
LONG
Jan 9. 2020
3.86
Jan 24. 2020
4.28
10 Trading Days
10.80%
Link
LONG
Feb 6. 2020
4.51
Feb 24. 2020
4.76
11 Trading Days
5.45%
Link
LONG
Mar 25. 2020
1.97
Mar 27. 2020
2.10
2 Trading Days
6.85%
Link
LONG
Apr 24. 2020
1.98
May 4. 2020
2.11
6 Trading Days
6.57%
Link
LONG
May 6. 2020
2.30
May 21. 2020
3.54
11 Trading Days
54.05%
Link
LONG
Aug 3. 2020
3.98
Aug 14. 2020
4.57
9 Trading Days
14.74%
Link
LONG
Sep 25. 2020
2.54
Oct 12. 2020
2.89
11 Trading Days
13.72%
Link
LONG
Jan 12. 2021
2.58
Jan 27. 2021
3.70
10 Trading Days
43.31%
Link
LONG
Feb 10. 2021
4.09
Feb 11. 2021
4.34
1 Trading Days
6.11%
Link
LONG
Mar 10. 2021
3.13
Mar 16. 2021
3.48
4 Trading Days
11.02%
Link
LONG
Feb 4. 2022
2.16
Feb 28. 2022
2.44
15 Trading Days
12.75%
Link
Company Information
Stock Symbol
ACER
Exchange
NasdaqCM
Company URL
http://www.opexatherapeutics.com
Company Phone
(281) 272-9331
CEO
Neil K. Warma
Headquarters
Texas
Business Address
2635 TECHNOLOGY FOREST BLVD., THE WOODLANDS, TX 77381
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001069308
About

Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX.

Description

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The company's lead product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. It is also developing OPX-212 as an autologous T-cell immunotherapy that is in preclinical development to treat neuromyelitis optica. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics, Inc. was founded in 2003 and is based in The Woodlands, Texas.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading